Opthea (OPT) News Today $3.24 -0.14 (-4.14%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Opthea Appoints Kathy Connell to Board of DirectorsNovember 15 at 7:00 AM | globenewswire.comOpthea Limited Appoints New Director with Stock OptionsNovember 15 at 1:03 AM | markets.businessinsider.comOpthea Limited Advances in Wet AMD TreatmentNovember 14 at 7:01 PM | tipranks.comOpthea Limited Strengthens Board Amidst Key Data PreparationsNovember 14 at 7:01 PM | tipranks.comOpthea’s Wet AMD Program Featured at Ophthalmology EventsNovember 12, 2024 | finance.yahoo.comOpthea to Highlight Promising AMD Therapy at Key EventsNovember 12, 2024 | markets.businessinsider.comOpthea (NASDAQ:OPT) Shares Up 1.7% - What's Next?Opthea (NASDAQ:OPT) Stock Price Up 1.7% - Time to Buy?November 9, 2024 | marketbeat.comOpthea Limited: Major Catalyst In Early 2025 For Complementary Eye Disease CandidateNovember 8, 2024 | seekingalpha.comOpthea to Participate in November Investor ConferencesNovember 5, 2024 | markets.businessinsider.comOpthea Limited to Present at Key November Investor ConferencesNovember 4, 2024 | markets.businessinsider.comOpthea Set to Highlight Innovations at Investor ConferencesNovember 3, 2024 | msn.comFY2025 EPS Estimates for Opthea Raised by Leerink PartnrsOpthea Limited (NASDAQ:OPT - Free Report) - Research analysts at Leerink Partnrs increased their FY2025 earnings per share (EPS) estimates for Opthea in a report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($1.15) perOctober 18, 2024 | marketbeat.comOpthea (NASDAQ:OPT) Stock Price Down 0.2% - Should You Sell?Opthea (NASDAQ:OPT) Stock Price Down 0.2% - Should You Sell?October 11, 2024 | marketbeat.comOpthea Wet AMD Program to be Presented at Innovate RetinaOctober 10, 2024 | globenewswire.comOpthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025October 8, 2024 | finance.yahoo.comOpthea Hires Financial Chief Ahead of 2025 Trial ReadoutsOctober 8, 2024 | marketwatch.comOpthea to Participate in the UBS Virtual Ophthalmology Day 2024September 30, 2024 | globenewswire.comWhy Atlas Arteria, Coles, Healius, and Opthea shares are falling todaySeptember 24, 2024 | msn.comOpthea Joins the S&P/ASX 300 IndexSeptember 23, 2024 | markets.businessinsider.comWhy Lotus Resources, Opthea, Qoria, and Sims shares are charging higher todaySeptember 19, 2024 | msn.comOpthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of SoziniberceptSeptember 18, 2024 | globenewswire.comOpthea to Have Significant Presence at the 24?? EURETINA Congress and EURETINA Innovation SpotlightSeptember 10, 2024 | tmcnet.comOpthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation SpotlightSeptember 10, 2024 | globenewswire.comFY2025 EPS Estimates for Opthea Limited (NASDAQ:OPT) Boosted by HC WainwrightOpthea Limited (NASDAQ:OPT - Free Report) - Research analysts at HC Wainwright boosted their FY2025 earnings estimates for Opthea in a note issued to investors on Tuesday, September 3rd. HC Wainwright analyst M. Caufield now forecasts that the company will post earnings of ($0.25) per share for tSeptember 6, 2024 | marketbeat.comOptimistic Buy Rating for Opthea Limited Amid Anticipated Success of Sozinibercept TrialsSeptember 5, 2024 | markets.businessinsider.comOpthea Limited (NASDAQ:OPT) to Post FY2029 Earnings of $0.50 Per Share, HC Wainwright ForecastsOpthea Limited (NASDAQ:OPT - Free Report) - Investment analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for Opthea in a note issued to investors on Tuesday, September 3rd. HC Wainwright analyst M. Caufield expects that the company will post earnings per share of $0September 5, 2024 | marketbeat.comOpthea Names Daniel Geffken CFO Ad Interim - Quick FactsSeptember 5, 2024 | markets.businessinsider.comOpthea Announces Executive Leadership Changes and Senior HiresSeptember 5, 2024 | globenewswire.comBuy Rating Affirmed for Opthea Limited Amid Promising Wet AMD Combination Therapy TrialsSeptember 3, 2024 | markets.businessinsider.comIs Opthea (OPT) The Best Australian Stock To Buy According to Hedge Funds?September 3, 2024 | finance.yahoo.comOpthea (NASDAQ:OPT) PT Lowered to $12.00 at HC WainwrightHC Wainwright decreased their price target on Opthea from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Tuesday.September 3, 2024 | marketbeat.comOpthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare ConferenceSeptember 3, 2024 | globenewswire.comOpthea Full Year 2024 Earnings: Misses ExpectationsAugust 31, 2024 | finance.yahoo.comOpthea Ltd (OPT)August 31, 2024 | investing.comOpthea Limited: Opthea Reports Full-Year Financial Results and Business UpdatesAugust 30, 2024 | finanznachrichten.deBell Potter Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)August 30, 2024 | markets.businessinsider.comOpthea Reports Full-Year Financial Results and Business UpdatesAugust 30, 2024 | globenewswire.com2 promising small-cap ASX healthcare stocks to buy nowAugust 27, 2024 | msn.comOpthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15, 2024August 8, 2024 | globenewswire.com'Blockbuster opportunity': This speculative ASX stock could rise 70%July 24, 2024 | msn.comOpthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory BoardJuly 17, 2024 | globenewswire.comOpthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement OfferJuly 14, 2024 | globenewswire.comOpthea A$55.0m (US$36.9m¹) Retail Entitlement Offer OpensJune 18, 2024 | globenewswire.comOpthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)June 13, 2024 | globenewswire.comOpthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)June 11, 2024 | globenewswire.comOpthea To Present at Clinical Trials at the Summit MeetingJune 3, 2024 | globenewswire.comOpthea Limited: Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMDMay 28, 2024 | finanznachrichten.de2 Stocks Under $10 Wall Street Says Are 'Strong Buys'May 28, 2024 | theglobeandmail.comOpthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMDMay 28, 2024 | globenewswire.comCRITERION: Looking for a clinical approach to predicting trial outcomes? AI is there for youMay 25, 2024 | msn.com Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now OPT Media Mentions By Week OPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼0.450.55▲Average Medical News Sentiment OPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼71▲OPT Articles Average Week Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRTA News CGEM News PLRX News ERAS News NGNE News DNTH News EOLS News TYRA News REPL News RLAY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Opthea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPT Stock Alerts